AvenCell received both FDA IND clearance and EMA approval of its Clinical Trial Application (CTA) for the QUADvance study on first submission in late 2025, enabling trial initiation at multiple sites ...

A key cancer-fighting gene in leukemia is switched off—not broken—and scientists from The Jackson Laboratory (JAX) found a ...

Durable expression of anti-sickling fetal hemoglobin and reduction in sickle hemoglobin ob ...

What did the recent study using the crispr gene editing technique actually entail, and what did we learn from it? Hosted by: ...

Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...

In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally ...

A research group led by Associate Professor Tetsuya Muramoto from the Faculty of Science, Toho University, has established a CRISPR genome editing technique that enables comparative analysis of the ...

Gene editing is a numbers game. For any genetic tweaks to have notable impact, a sufficient number of targeted cells need to have the disease-causing gene deleted or replaced. Despite a growing ...

New policies limiting the teaching of race and gender issues led administrators and professors to change hundreds of courses. School leaders say the rules could hurt A&M’s reputation. By Alan Blinder ...

This study presents an advance in efforts to use histone post-translational modification (PTM) data to model gene expression and predict epigenetic editing activity. Such models are broadly useful to ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...